Table of Contents
The Brown University Child & Adolescent Psychopharmacology Update · 2005
DOI: 10.1002/cpu.20009 ↗Santrauka
Abstract Experts Discuss Complete Review of Published, Unpublished Data on SSRI Use in Children Evaluating the Risks for Treating Depression with SSRIs During Pregnancy FDA Recommended Frequency of Visits Oxcarbazepine in Youth with Bipolar Disorder MPH Reinforces Cigarette Smoking in Small Group of non‐ADHD Adults Boxed Warning Added to Adderall Label FDA to Reject Long‐Term Efficacy Requirement Study Finds Buprenorphine Best add‐on to Counseling MIT Launches Autism Research Initiative Severe Liver Injury with Atomoxetine FDA Warns of Liver Damage from Pemoline Cymbalta Label Extends Liver Damage Warning FDA Approves Modafinil for ADHD
EUVIMED